Disease activity impacts disability progression in primary progressive multiple sclerosis

M Marrodan1, C Bensi1, A Pappolla2

  • 1Department of Neurology, Fleni, Montañeses 2325 (1428), Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina.

Abstract

Insights

Disease activity and older age at onset accelerate disability progression in primary progressive multiple sclerosis (PPMS). This study highlights key factors influencing PPMS worsening, aiding in better patient management.

Area of Science:

  • Neurology
  • Clinical Research
  • Multiple Sclerosis

Background:

  • Limited consensus exists on how disease activity impacts the progression of primary progressive multiple sclerosis (PPMS).
  • Understanding the natural history and factors influencing PPMS is crucial for effective patient care.

Purpose of the Study:

  • To characterize a PPMS cohort in Argentina regarding clinical features, MRI activity, and disease progression.
  • To determine if clinical or radiological disease activity correlates with worsening disability in PPMS patients.

Main Methods:

  • Retrospective analysis of 178 primary progressive multiple sclerosis patients from two referral centers in Buenos Aires, Argentina.
  • Comparative assessment of patients with and without evidence of disease activity.
  • Correlation analysis between age at onset, disease activity, and disability progression (EDSS scores).

Main Results:

  • 56% of patients (31%) exhibited clinical and/or radiological disease activity.
  • Increased age at onset correlated with higher Expanded Disability Status Scale (EDSS) scores.
  • Clinical exacerbations and gadolinium-enhancing lesions were associated with faster disability progression.

Conclusions:

  • Older age at onset is linked to accelerated disability progression in PPMS.
  • Clinical and radiological disease activity significantly correlates with faster worsening of disability in primary progressive multiple sclerosis patients.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
890
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K